ArticleThe Lancet. Public health2022

The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study.

Sébastien Morin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.